The landscape of dementia diagnosis has developed considerably with the arrival of innovative biomarkers, which include amyloid PET scans, tau imaging, and blood-dependent exams that will detect Alzheimer's pathology many years prior to symptoms arise. Even though these technological developments represent extraordinary development in knowing neurodegenerative illnesses, they may have https://edwinb086zjs5.topbloghub.com/profile